MedTrace Logo

Detection Rate of Prostate Cancer in Men Undergoing MRI

NCT04398173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-04-14

No results posted yet for this study

Summary

To assess prostate cancer (PCa) detection rate in men undergoing magnetic resonance imaging (MRI) before planning prostate biopsy. Results will be stratified considering men with/without previous negative prostate biopsy.

Secondary objective will be to compute the negative predictive value of MRI in subject with no lesion detected at imaging or no cancer confirmed at biopsy, considering a follow-up of at least 2 years.

Conditions

  • Prostatic Neoplasm

Interventions

DIAGNOSTIC_TEST

multiparametric MRI

T1-w, T2-w, diffusion weighted and dynamic contrast-enhanced imaging

Sponsors & Collaborators

  • Fondazione del Piemonte per l'Oncologia

    lead OTHER

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2020-10-31
Completion
2020-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04398173 on ClinicalTrials.gov